Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Linder

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 25, 2015
The costs and consequences of obesity in Germany: a new approach from a prevalence and life-cycle perspectiveTobias Effertz, Susanne Engel, Frank Verheyen, et al.
Plos One|March 4, 2014
Estimating colorectal cancer treatment costs: a pragmatic approach exemplified by health insurance data from GermanyUlrike Haug, Susanne Engel, Frank Verheyen, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 20, 2013
Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative dataSimon Frey, Roland Linder, Georg Juckel, et al.
Statistics in Medicine|June 12, 2018
Robust versus consistent variance estimators in marginal structural Cox modelsDirk Enders, Susanne Engel, Roland Linder, et al.
European Journal of Endocrinology|December 11, 2013
Increasing prevalence of Addison's disease in German females: health insurance data 2008-2012Gesine Meyer, Kathrin Neumann, Klaus Badenhoop, et al.
Arthritis and Rheumatism|April 11, 2003
Use of an artificial neural network to predict cancer development in patients with inflammatory myopathy: comment on the letter by Selva O'Callaghan et alRoland Linder, Eva Reinhold-Keller, Wolfgang L Gross
Deutsche Medizinische Wochenschrift (1946)|January 18, 2019
[Guideline-Orientated Prescription of Disease-Modifying Drugs in Patients with Rheumatoid Arthritis - an Analysis Based on Social Health Insurance Claims Data]Sarah Neubauer, Henning Zeidler, Roland Linder, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|November 20, 2015
[Do nursing homes with higher quality ratings provide a better quality of care? : Empirical study based on administrative data]Adam Przylog, Magdalena A Stroka, Susanne Engel, et al.
Clinical Therapeutics|May 4, 2016
Corrigendum to "Descriptive Comparison of Drug Treatment-Persistent, - Nonpersistent, and Nondrug Treatment Patients With Newly Diagnosed Attention Deficit/Hyperactivity Disorder in Germany" Clin Ther 2013;35:673-685Sebastian Braun, Leo Russo, Jan Zeidler, et al.
BMC Public Health|February 8, 2025
COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysisRoland Linder, Jonas Peltner, Anatoli Astvatsatourov, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 25, 2015
The costs and consequences of obesity in Germany: a new approach from a prevalence and life-cycle perspectiveTobias Effertz, Susanne Engel, Frank Verheyen, et al.
Plos One|March 4, 2014
Estimating colorectal cancer treatment costs: a pragmatic approach exemplified by health insurance data from GermanyUlrike Haug, Susanne Engel, Frank Verheyen, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 20, 2013
Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative dataSimon Frey, Roland Linder, Georg Juckel, et al.
Statistics in Medicine|June 12, 2018
Robust versus consistent variance estimators in marginal structural Cox modelsDirk Enders, Susanne Engel, Roland Linder, et al.
European Journal of Endocrinology|December 11, 2013
Increasing prevalence of Addison's disease in German females: health insurance data 2008-2012Gesine Meyer, Kathrin Neumann, Klaus Badenhoop, et al.
Arthritis and Rheumatism|April 11, 2003
Use of an artificial neural network to predict cancer development in patients with inflammatory myopathy: comment on the letter by Selva O'Callaghan et alRoland Linder, Eva Reinhold-Keller, Wolfgang L Gross
Deutsche Medizinische Wochenschrift (1946)|January 18, 2019
[Guideline-Orientated Prescription of Disease-Modifying Drugs in Patients with Rheumatoid Arthritis - an Analysis Based on Social Health Insurance Claims Data]Sarah Neubauer, Henning Zeidler, Roland Linder, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|November 20, 2015
[Do nursing homes with higher quality ratings provide a better quality of care? : Empirical study based on administrative data]Adam Przylog, Magdalena A Stroka, Susanne Engel, et al.
Clinical Therapeutics|May 4, 2016
Corrigendum to "Descriptive Comparison of Drug Treatment-Persistent, - Nonpersistent, and Nondrug Treatment Patients With Newly Diagnosed Attention Deficit/Hyperactivity Disorder in Germany" Clin Ther 2013;35:673-685Sebastian Braun, Leo Russo, Jan Zeidler, et al.
BMC Public Health|February 8, 2025
COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysisRoland Linder, Jonas Peltner, Anatoli Astvatsatourov, et al.
Pageof 8